Takeda says cancer drug Alunbrig shows longer benefit vs. crizotinib
(This Nov. 23rd story corrects fiscal year of expected regulatory approval in the 10th paragraph to March-end 2021, not March-end…
by October Gallery
by October Gallery
(This Nov. 23rd story corrects fiscal year of expected regulatory approval in the 10th paragraph to March-end 2021, not March-end…